Effects of inhaled corticosteroids on systemic blood pressure in preterm infants

Area of Science:

• Neonatalogy
• Pharmacology
• Respiratory Medicine

Background:

• Preterm infants, particularly very low birth weight (VLBW) neonates, often experience hypotension requiring interventions.
• Systemic blood pressure management is critical in the early postnatal period for VLBW infants.

Purpose of the Study:

• To evaluate the efficacy of inhaled fluticasone propionate in managing systemic blood pressure in preterm VLBW infants.
• To determine if fluticasone propionate reduces the requirement for volume expanders and inotropes for blood pressure support.

Main Methods:

• Randomized controlled trial involving ventilated VLBW infants (<32 weeks gestation) with respiratory distress syndrome.
• Participants received either inhaled fluticasone propionate or placebo for 14 days via a metered dose inhaler-spacer.
• Blood pressures and the use of volume expanders (crystalloids, colloids) and inotropes were compared between groups.

Main Results:

• No significant differences were observed in systolic, mean, or diastolic blood pressures between the fluticasone and placebo groups.
• Infants treated with fluticasone propionate required significantly less crystalloid and colloid volume expanders compared to the control group.
• A trend towards lower dopamine use was noted in the fluticasone-treated group, though not statistically significant.

Conclusions:

• Inhaled fluticasone propionate administration led to a significant reduction in the need for volume expanders in preterm VLBW infants.
• Further large-scale studies are warranted to confirm the potential of inhaled corticosteroids in minimizing volume replacement therapy and inotropic support for neonatal hypotension.